{"id":"W4392125931","doi":"10.1093/ofid/ofae102","title":"COVID-19 Immunologic Antiviral Therapy With Omalizumab (CIAO)—a Randomized Controlled Clinical Trial","year":2024,"lang":"en","type":"article","venue":"Open Forum Infectious Diseases","topic":"Urticaria and Related Conditions","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Niagara Health System; Sunnybrook Health Science Centre; Institute of Infection and Immunity; University of British Columbia; Health Sciences Centre; McGill University","funders":"Fonds de Recherche du Québec - Santé; Sanofi Genzyme; Bausch Health; LEO Pharma; Galderma; Novartis Pharmaceuticals Corporation; AbbVie; Sanofi; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Omalizumab; Coronavirus disease 2019 (COVID-19); Randomized controlled trial; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); 2019-20 coronavirus outbreak; Virology; Intensive care medicine; Immunology; Antibody; Internal medicine; Immunoglobulin E; Outbreak","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007058548,0.0003120013,0.001854653,0.0002026306,0.0003698356,0.000419785,0.000207637,0.0002313112,0.001801772],"category_scores_gemma":[0.001945778,0.0001689941,0.001054955,0.0003673654,0.0005890236,0.0002553228,0.0001010775,0.0004215616,0.0002033361],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001274077,"about_ca_system_score_gemma":0.001928569,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002085828,"about_ca_topic_score_gemma":0.0000256982,"domain_scores_codex":[0.9972309,0.0007597128,0.0008201103,0.0005269966,0.0002664997,0.0003957852],"domain_scores_gemma":[0.9969825,0.001890108,0.0001724611,0.0004213105,0.00009501818,0.0004386377],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.963367,0.001829981,0.004561978,0.00001898556,0.008698723,0.0005962237,0.00006077002,0.000007347763,0.00001666435,0.01253683,0.005930636,0.002374839],"study_design_scores_gemma":[0.9748988,0.004589618,0.0005097504,0.0001147355,0.005141953,0.0001789207,0.0001014042,0.0004227982,0.000008030987,0.005684493,0.008076923,0.000272601],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8496414,0.01337005,0.001050525,0.01523461,0.003507604,0.02451362,0.0001544769,0.001542411,0.09098531],"genre_scores_gemma":[0.9902473,0.00179943,0.0000227752,0.003170723,0.0002479654,0.001736736,0.0001361589,0.00004806481,0.002590842],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1406059,"threshold_uncertainty_score":0.9991107,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03101811218743415,"score_gpt":0.3744055311444537,"score_spread":0.3433874189570196,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}